SPONSOR
Baycrest
Total Trials
3
Recruiting
3
Phases
N/A
Conditions studied: Progressive Supranuclear PalsyCortical Basal Ganglionic DegenerationParkinson DiseaseAlzheimer DiseasePreventionDementia
Baycrest is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Progressive Supranuclear Palsy, Cortical Basal Ganglionic Degeneration, Parkinson Disease, Alzheimer Disease.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Baycrest
How many clinical trials has Baycrest sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Baycrest, of which 3 are actively recruiting participants. These trials cover conditions including Progressive Supranuclear Palsy, Cortical Basal Ganglionic Degeneration, Parkinson Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Baycrest research focus on?
Baycrest clinical trials span Progressive Supranuclear Palsy, Cortical Basal Ganglionic Degeneration, Parkinson Disease, Alzheimer Disease, Prevention, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Baycrest clinical trial?
To participate in a Baycrest trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Baycrest trials with current recruitment status updated daily.
Clinical Trials by Baycrest
NCT07291687
Recruiting
tDCS as Treatment for Motor Function
Progressive Supranuclear Palsy
NCT05508841
Recruiting
Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation
Alzheimer Disease
NCT06933667
Recruiting
Kimel Family Centre for Brain Health and Wellness
Prevention
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology